⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29810697 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4969077 | 0.97 | MMP2 (0.45) | — | |
| SCHEMBL416446 | 0.80 | — | — | |
| SCHEMBL1172644 | 0.80 | — | — | |
| SCHEMBL14840044 | 0.77 | CRHBP (0.46) | — | |
| Hydrochloric Acid SCHEMBL10875382 | 0.77 | MMP2 (0.54) | — | |
| SCHEMBL724770 | 0.72 | — | — | |
| SCHEMBL5556 | 0.72 | — | — | |
| SCHEMBL69568 | 0.72 | — | — | |
| SCHEMBL1013212 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 562 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322110-B | Method for synthesizing eltrombopag intermediate 3 '-amino-2' -hydroxybiphenyl-3-carboxylic acid | 常熟理工学院 | 2024-03-19 | — | — | CN | claimed |
| CN-112321454-B | Eltrombopag intermediate, preparation method thereof and method for preparing Ai Qubo Pa by using same | 长沙创新药物工业技术研究院有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-115322110-A | Method for synthesizing eltrombopag intermediate 3 '-amino-2' -hydroxybiphenyl-3-carboxylic acid | 常熟理工学院 | 2022-11-11 | — | — | CN | claimed |
| CN-113862702-A | Synthesis method for preparing phenoxazinone compound by electrochemically oxidizing o-aminophenol analog | 温州医科大学 | 2021-12-31 | — | — | CN | claimed |
| CN-112321454-A | Elotriporpa intermediate, preparation method thereof and method for preparing Elotriporpa by using intermediate | 湖南华腾制药有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-108191763-A | A kind of synthetic method of Ai Qu pools pa ethanol amine | 扬子江药业集团四川海蓉药业有限公司 | 2018-06-22 | — | — | CN | claimed |
| US-12637449-B2 | Organic compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| CN-122036680-A | Anti-fibrotic pyridones | 英特穆恩公司 | 2026-05-15 | — | — | CN | disclosed |
| WO-2026098667-A1 | USP30 INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 长春金赛药业有限责任公司 | 2026-05-15 | — | — | WO | disclosed |
| EP-4735452-A2 | HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN | Merck Patent GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735438-A2 | HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS | Merck Patent GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-3886904-B1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260083721-A1 | 7-CYANO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | JIANGSU YAHONG MEDITECH CO LTD (CN) | 2026-03-26 | — | — | US | disclosed |
| US-6372770-B1 | TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF | EURO-CELTIQUE, S.A. | 2002-04-16 | — | — | US | disclosed |
| US-6365606-B1 | TREATMENT OF DISEASES WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF CYTOKINES; SIDE EFFECT REDUCTION; ISOINDOLES; BRONCHODILATOR; ANTI-INFLAMMATORY AGENT | EURO-CELTIQUE, S.A. (LU) | 2002-04-02 | — | — | US | disclosed |
| EP-1160247-A1 | 6,5-Fused aromatic ring systems having enhanced phosphodiesterae IV inhibitory activity | Euro-Celtique S.A. (LU) | 2001-12-05 | — | — | EP | disclosed |
| US-6075016-A | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity | EURO-CELTIQUE S.A. (LU) | 2000-06-13 | — | — | US | disclosed |
| EP-0785927-A4 | NOVEL BENZOXAZOLES | EURO CELTIQUE SA (LU) | 1997-12-29 | — | — | EP | disclosed |
| EP-0785927-A1 | NOVEL BENZOXAZOLES | Euroceltique S.A. (LU) | 1997-07-30 | — | — | EP | disclosed |
| WO-1996011917-A1 | NOVEL BENZOXAZOLES | EURO-CELTIQUE, S.A. (LU) | 1996-04-25 | — | — | WO | disclosed |